Skip to main content

RITHOLTZ WEALTH MANAGEMENT

Position in ABT — Abbott Laboratories

CIK 1698218 NEW YORK, NY

Position in ABT

as of Mar 31, 2026 · filed Apr 20, 2026
Position Value
$5,303,726
-$1,693,344 QoQ
Shares Held
51,658
-7.5% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority Sole 1.358937628247319.ToString("F0")% Shared 0.ToString("F0")% None 98.64106237175268.ToString("F0")%

Common Shares in ABT Over Time

Shares Held

Position Value (USD)

Derivatives in ABT

reported options exposure · as of Jun 30, 2021
CallValue
$162,302
CallShares
1,400
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Devices

Healthcare · as of Mar 31, 2026

RITHOLTZ WEALTH MANAGEMENT holds $19,288,555 across 12 Medical Devices names. ABT ranks #2 (27.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 ABT
Abbott Laboratories
This page
51,658 $5,303,726

All Filings in ABT

Export CSV
28 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $5,303,726 51,658
2025-12-31 $6,997,070 55,847
2025-09-30 $7,849,955 58,608
2025-06-30 $8,960,066 65,878
2025-03-31 $6,411,239 48,332
2024-12-31 $5,025,137 44,427
2024-09-30 $4,776,334 41,894
2024-06-30 $4,251,062 40,911
2024-03-31 $4,648,353 40,897
2023-12-31 $4,077,653 37,046
2023-09-30 $3,505,776 36,198
2023-06-30 $3,562,010 32,673
2023-03-31 $2,745,057 27,109
2022-12-31 $6,339,603 57,743
2022-09-30 $3,047,649 31,497
2022-06-30 $3,077,728 28,327
2022-03-31 $4,841,397 40,904
2021-12-31 $1,338,437 9,510
2021-09-30 $904,757 7,659
2021-06-30 $651,294 5,618
2021-06-30 $162,302 1,400
2021-03-31 $786,989 6,567
2020-12-31 $120,439 1,100
2020-12-31 $513,508 4,690
2020-09-30 $425,198 3,907
2020-09-30 $163,245 1,500
2020-06-30 $118,859 1,300
2020-06-30 $293,764 3,213